Yari Ciribilli

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Journal of clinical medicine

Scientific reports

Cell death & disease

International journal of molecular sciences

University of Genova (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Genova Jan 01 2006 - Apr 24 2009

Italy

PHD :: National Cancer Research Institute

Publications

Antonella Ferro, Michela Campora, Alessia Caldara, Delia De Lisi, Martina Lorenzi, Sara Monteverdi, Raluca Mihai, Alessandra Bisio, Mariachiara Dipasquale, Orazio Caffo, Yari Ciribilli
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of clinical medicine 13 (12) (2024)
Antonella Ferro, Michela Campora, Alessia Caldara, Delia De Lisi, Martina Lorenzi, Sara Monteverdi, Raluca Mihai, Alessandra Bisio, Mariachiara Dipasquale, Orazio Caffo, Yari Ciribilli
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of clinical medicine 13 (12) (2024)
Erna Marija Meškytė, Laura Pezzè, Laura Bartolomei, Mattia Forcato, Irene Adelaide Bocci, Giovanni Bertalot, Mattia Barbareschi, Leticia Oliveira-Ferrer, Alessandra Bisio, Silvio Bicciato, Daiva Baltriukienė, Yari Ciribilli
ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis. Cell death & disease 14 (4) (2023)
Matilde Fregni, Yari Ciribilli, Joanna E Zawacka-Pankau
The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR -Mutated Lung Cancer. International journal of molecular sciences 23 (13) (2022)
Ana Dekanić, Francesca Precazzini, Nikolina Hanžić, Martina Radić, Nicolò Gavioli, Ignacija Vlašić, Petar Ozretić, Lia Pinto, Lidija Škreblin, Giulia Barban, Neda Slade, Yari Ciribilli
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness. Cancers 13 (20) (2021)
Laura Pezzè, Erna Marija Meškytė, Mattia Forcato, Stefano Pontalti, Kalina Aleksandra Badowska, Dario Rizzotto, Ira-Ida Skvortsova, Silvio Bicciato, Yari Ciribilli
ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes. Cell death & disease 12 (8) (2021)
Erna Marija Meškytė, Sabiha Keskas, Yari Ciribilli
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. International journal of molecular sciences 21 (20) (2020)
Petar Ozretić, Nikolina Hanžić, Bastien Proust, Maja Sabol, Diana Trnski, Martina Radić, Vesna Musani, Yari Ciribilli, Ivan Milas, Zvonimir Puljiz, Maja Herak Bosnar, Sonja Levanat, Neda Slade
Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines. Scientific reports 9 (1) (2019)
Isar Nassiri, Alberto Inga, Erna Marija Meškytė, Federica Alessandrini, Yari Ciribilli, Corrado Priami
Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines. Scientific reports 9 (1) (2019)
Marica Pinazza, Margherita Ghisi, Sonia Minuzzo, Valentina Agnusdei, Gianluca Fossati, Vincenzo Ciminale, Laura Pezzè, Yari Ciribilli, Giorgia Pilotto, Carolina Venturoli, Alberto Amadori, Stefano Indraccolo
Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells. Oncogene 37 (28) (2018)

Yari Ciribilli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yari Ciribilli